Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -832 | -435 | -322 | -263 | -801 |
| Depreciation Amortization | 183 | 86 | 68 | 50 | 85 |
| Accounts receivable | 5 | -37 | 1 | -108 | 29 |
| Accounts payable and accrued liabilities | 334 | 359 | 298 | 132 | 25 |
| Other Working Capital | 491 | 213 | 208 | 128 | 48 |
| Other Operating Activity | -313 | -322 | -299 | -24 | -19 |
| Operating Cash Flow | $-131 | $-135 | $-46 | $-85 | $-634 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | 0 | N/A | -13 |
| Purchase Sale Intangibles | -118 | -91 | -36 | -8 | -93 |
| Other Investing Activity | -118 | -91 | -36 | -8 | -93 |
| Investing Cash Flow | $-118 | $-91 | $-37 | $-8 | $-106 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 383 | 310 | 150 | 150 | 394 |
| Other Financing Activity | -174 | -126 | -108 | -64 | 46 |
| Financing Cash Flow | $209 | $184 | $42 | $86 | $440 |
| Beginning Cash Position | 217 | 42 | 42 | 42 | 342 |
| End Cash Position | 177 | N/A | 2 | 35 | 42 |
| Net Cash Flow | $-41 | $-42 | $-41 | $-7 | $-299 |
| Free Cash Flow | |||||
| Operating Cash Flow | -131 | -135 | -46 | -85 | -634 |
| Capital Expenditure | 0 | 0 | 0 | N/A | -13 |
| Free Cash Flow | -131 | -135 | -46 | -85 | -646 |